pyridine has been researched along with Breast Cancer in 7 studies
azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To induce a safe death to MCF-7 human breast cancer cell line through gene therapy based on iC9 suicide gene." | 1.51 | Carbon nanotube-delivered iC9 suicide gene therapy for killing breast cancer cells in vitro. ( Akbari-Birgani, S; Kaboudin, B; Madadi, Z; Mohseni-Dargah, M; Saghatchi, F, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández-Borja, F | 1 |
| Mercado-Sánchez, I | 1 |
| Alcaraz, Y | 1 |
| García-Revilla, MA | 1 |
| Villegas Gómez, C | 1 |
| Ordaz-Rosado, D | 1 |
| Santos-Martínez, N | 1 |
| García-Becerra, R | 1 |
| Vazquez, MA | 1 |
| Nourizadeh, S | 1 |
| Divsalar, A | 1 |
| Fekri, M | 1 |
| Ghalandari, B | 1 |
| Eslami-Moghadam, M | 1 |
| Akbar Saboury, A | 1 |
| Abbasi, S | 1 |
| Mohseni-Dargah, M | 1 |
| Akbari-Birgani, S | 1 |
| Madadi, Z | 1 |
| Saghatchi, F | 1 |
| Kaboudin, B | 1 |
| Oral, AY | 1 |
| Cevatemre, B | 1 |
| Sarimahmut, M | 1 |
| Icsel, C | 1 |
| Yilmaz, VT | 1 |
| Ulukaya, E | 1 |
| Ghorab, MM | 1 |
| Alsaid, MS | 1 |
| Al-Dosari, MS | 1 |
| Ragab, FA | 1 |
| Al-Mishari, AA | 1 |
| Almoqbil, AN | 1 |
| Elwell, KE | 1 |
| Hall, C | 1 |
| Tharkar, S | 1 |
| Giraud, Y | 1 |
| Bennett, B | 1 |
| Bae, C | 1 |
| Carper, SW | 1 |
| Schatzschneider, U | 1 |
| Niesel, J | 1 |
| Ott, I | 1 |
| Gust, R | 1 |
| Alborzinia, H | 1 |
| Wölfl, S | 1 |
7 other studies available for pyridine and Breast Cancer
| Article | Year |
|---|---|
Exploring novel capping framework: high substituent pyridine-hydroxamic acid derivatives as potential antiproliferative agents.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent K | 2021 |
Multiple Spectroscopic, Docking and Cytotoxic Study of a Synthesized 2,2' Bipyridin Phenyl Isopentylglycin Pt(II) Nitrate Complex: Human Serum Albumin and Breast Cancer Cell Line of MDA-MB231 as Targets.
Topics: Antineoplastic Agents; Binding Sites; Breast Neoplasms; Humans; MCF-7 Cells; Molecular Docking Simul | 2018 |
Carbon nanotube-delivered iC9 suicide gene therapy for killing breast cancer cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Breast Neoplasms; Caspase 9; Cell Survival; Combine | 2019 |
Anti-growth effect of a novel trans-dichloridobis[2-(2-hydroxyethyl)pyridine]platinum (II) complex via induction of apoptosis on breast cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Pro | 2015 |
Novel quinolines carrying pyridine, thienopyridine, isoquinoline, thiazolidine, thiazole and thiophene moieties as potential anticancer agents.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Drug Desig | 2016 |
A fluorine containing bipyridine cisplatin analog is more effective than cisplatin at inducing apoptosis in cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Female; Fluorine Compounds; Humans; L | 2006 |
Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium(II) polypyridyl complexes [Ru(bpy)2(N--N)]Cl2 with N--N=bpy, phen, dpq, dppz, and dppn.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cisplatin; HT29 Cells; Humans; Organometa | 2008 |